DARE - Dare Bioscience GAAP EPS of -$0.37 misses by $0.07 revenue of $10M in-line
2023-03-30 08:31:03 ET
- Dare Bioscience press release ( NASDAQ: DARE ): FY GAAP EPS of -$0.37 misses by $0.07 .
- Revenue of $10M in-line.
- Cash and cash equivalents: $34.7 million at December 31, 2022, compared to $51.7 million at December 31, 2021.
- Shares +5.77% PM.
For further details see:
Dare Bioscience GAAP EPS of -$0.37 misses by $0.07, revenue of $10M in-line